Antihemophilic Factor (Recombinant [Pegylated-aucl]) and Moxetumomab pasudotox
Determining the interaction of Antihemophilic Factor (Recombinant [Pegylated-aucl]) and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Moxetumomab Pasudotox-tdfk
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Moxetumomab pasudotox-tdfk Intravenous
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Moxifloxacin
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Moxifloxacin (Systemic)
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Moxifloxacin Hydrochloride
- Antihemophilic Factor (Recombinant [Pegylated-aucl])-Moxifloxacin Injection
- Moxetumomab pasudotox-Antihemophilic Factor (Recombinant [Pegylated])
- Moxetumomab pasudotox-Antihemophilic Factor (Recombinant [Pegylated]) Injection
- Moxetumomab pasudotox-Antihemophilic Factor (Recombinant [Porcine Sequence])
- Moxetumomab pasudotox-Antihemophilic Factor (Recombinant) (Advate)
- Moxetumomab pasudotox-Antihemophilic Factor (Recombinant) (Afstyla)
- Moxetumomab pasudotox-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)